Level Biotechnology Inc. (TPEX:3118)

Level Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	186.76	252.78	467.41	463.5	472.96	380.32
Cash & Short-Term Investments	186.76	252.78	467.41	463.5	472.96	380.32
Cash Growth	-52.18%	-45.92%	0.84%	-2.00%	24.36%	10.42%
Accounts Receivable	147.25	113.79	110.35	118.39	96.15	152.05
Other Receivables	2.69	3.19	2.47	2.27	2.37	4.16
Receivables	149.94	116.98	112.82	120.66	98.52	156.21
Inventory	89.97	98.09	88.85	73.7	56.17	63.56
Prepaid Expenses	9.33	15.96	11.39	7.95	6.58	8.12
Other Current Assets	0.15	0.14	0.03	0.01	0.02	0.29
Total Current Assets	436.15	483.95	680.5	665.82	634.24	608.5
Property, Plant & Equipment	319.05	313.11	105.81	113.01	122.41	131.75
Long-Term Investments	8.01	-	-	-	-	-
Other Intangible Assets	-	-	-	0.02	0.05	0.07
Other Long-Term Assets	36.64	30.05	36.36	33.68	30.92	32.66
Total Assets	799.85	827.11	822.67	812.53	787.62	772.99
Accounts Payable	41.74	52.93	50.47	65.34	48.01	73.66
Accrued Expenses	-	24.92	-	-	-	-
Current Portion of Leases	4.47	4.7	3.53	2.77	2.22	2.66
Current Income Taxes Payable	5.14	8.4	8.35	6.35	9.56	8.2
Current Unearned Revenue	139.05	153.23	154.34	151.13	128.11	109.66
Other Current Liabilities	35.33	8.3	36.08	29	37.27	30.39
Total Current Liabilities	225.72	252.49	252.76	254.59	225.17	224.55
Long-Term Leases	4.7	7.98	9.89	9.8	10.96	13.18
Pension & Post-Retirement Benefits	6.37	6.48	7.43	5.49	6.4	5.58
Other Long-Term Liabilities	0.25	0.25	3.13	0.25	0.25	0.25
Total Liabilities	237.03	267.19	273.2	270.13	242.78	243.56
Common Stock	324.53	324.53	324.53	324.53	324.53	324.53
Additional Paid-In Capital	56.05	56.05	56.05	56.05	56.05	55.99
Retained Earnings	182.24	179.34	168.9	161.83	164.27	148.91
Shareholders' Equity	562.82	559.91	549.47	542.4	544.84	529.43
Total Liabilities & Equity	799.85	827.11	822.67	812.53	787.62	772.99
Total Debt	9.16	12.68	13.41	12.57	13.18	15.83
Net Cash (Debt)	177.59	240.1	453.99	450.92	459.78	364.49
Net Cash Growth	-52.86%	-47.11%	0.68%	-1.93%	26.15%	11.38%
Net Cash Per Share	5.44	7.35	13.90	13.80	14.08	11.18
Filing Date Shares Outstanding	32.45	32.45	32.45	32.45	32.45	32.45
Total Common Shares Outstanding	32.45	32.45	32.45	32.45	32.45	32.45
Working Capital	210.42	231.46	427.74	411.22	409.06	383.95
Book Value Per Share	17.34	17.25	16.93	16.71	16.79	16.31
Tangible Book Value	562.82	559.91	549.47	542.38	544.8	529.36
Tangible Book Value Per Share	17.34	17.25	16.93	16.71	16.79	16.31
Land	128.12	128.12	15.61	15.61	15.61	15.61
Buildings	338.65	320.29	211.76	211.76	210.42	210.42
Machinery	101.35	99.32	110.05	111.09	106.89	100.75

Source: S&P Global Market Intelligence. Standard template. Financial Sources.